Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer

This study has been terminated.
(funding terminated)
Indiana University School of Medicine
Emory University
Information provided by:
Hoosier Cancer Research Network Identifier:
First received: November 1, 2010
Last updated: April 27, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)